Literature DB >> 31922482

Evaluation of the composition of urinary tract stones in children from the Inner Western Anatolian Region in Turkey.

İlknur Girişgen1, Selçuk Yüksel2, Kadriye Karcılı3, Tülay Becerir1.   

Abstract

OBJECTIVE: Pediatric urolithiasis is a globally growing problem. The composition and frequency of urinary tract stones vary not only among different countries, but across various regions in a country. Hence, we aimed to identify the types and frequencies of urinary tract stones in children from our region (Inner Western Anatolian part of Turkey), and to compare our findings with the results from other regions in our country.
MATERIAL AND METHODS: In this retrospective analysis of 53 pediatric urolithiasis cases that were treated in our hospital between 2009 and 2019, the demographic data, clinical course, radiological and metabolic findings, the recurrence rate, and the composition of the stones were evaluated.
RESULTS: The mean age of the patients was 5.9±4.6 (0.5-18) years, and there were 30 (56.6%) girls and 23 (43.4%) boys. An analysis of the composition of the stones revealed that the majority (85%) consisted of calcium oxalate. The highest risk of recurrence and the need for multiple shockwave lithotripsy (SWL) sessions or surgical intervention appeared to be related with the presence of whewellite stones, which are the most challenging stones in childhood.
CONCLUSION: According the study results, the urinary stone types vary across different regions in our country, and the frequency of uric acid stones decreased going westward, while the frequency of oxalate stones increased. We conclude that this difference in the frequency of the type of urinary stones might reflect the regional dietary habits. Regional frequency and etiology studies for the types of urolithiasis may facilitate the approach to the treatment of urolithiasis.

Entities:  

Year:  2020        PMID: 31922482      PMCID: PMC7053989          DOI: 10.5152/tud.2019.19170

Source DB:  PubMed          Journal:  Turk J Urol        ISSN: 2149-3235


  29 in total

1.  Characteristics of pediatric urolithiasis in south-east Anatolia.

Authors:  A Ece; E Ozdemir; F Gürkan; A I Dokucu; O Akdeniz
Journal:  Int J Urol       Date:  2000-09       Impact factor: 3.369

2.  Paediatric urolithiasis in Greece.

Authors:  P A Androulakakis; V Michael; S Polychronopoulou; C Aghioutantis
Journal:  Br J Urol       Date:  1991-02

Review 3.  Pediatric urolithiasis: causative factors, diagnosis and medical management.

Authors:  Funda Baştuğ; Ruhan Düşünsel
Journal:  Nat Rev Urol       Date:  2012-02-07       Impact factor: 14.432

Review 4.  An update on the changing epidemiology and metabolic risk factors in pediatric kidney stone disease.

Authors:  David J Sas
Journal:  Clin J Am Soc Nephrol       Date:  2011-07-07       Impact factor: 8.237

5.  Metabolic and demographic characteristics of children with urolithiasis in Western Turkey.

Authors:  Pelin Ertan; Gökhan Tekin; Neşe Oger; Senem Alkan; Gönül Dinç Horasan
Journal:  Urol Res       Date:  2010-07-23

6.  Urolithiasis in childhood.

Authors:  B H Ozokutan; M Küçükaydin; Z Gündüz; M Kabaklioğlu; H Okur; C Turan
Journal:  Pediatr Surg Int       Date:  2000       Impact factor: 1.827

7.  Pediatric urolithiasis in Armenia: a study of 198 patients observed from 1991 to 1999.

Authors:  A Sarkissian; A Babloyan; N Arikyants; A Hesse; N Blau; E Leumann
Journal:  Pediatr Nephrol       Date:  2001-09       Impact factor: 3.714

8.  Family history and risk of kidney stones.

Authors:  G C Curhan; W C Willett; E B Rimm; M J Stampfer
Journal:  J Am Soc Nephrol       Date:  1997-10       Impact factor: 10.121

9.  Etiology of chronic renal failure in Turkish children.

Authors:  A Sirin; S Emre; H Alpay; A Nayir; I Bilge; F Tanman
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

10.  Relation between geographic variability in kidney stones prevalence and risk factors for stones.

Authors:  J M Soucie; R J Coates; W McClellan; H Austin; M Thun
Journal:  Am J Epidemiol       Date:  1996-03-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.